DDO-2728
Product Specifications
CAS Number
3029515-97-4
Target
Others
Applications
Others
Molecular Formula
C28H17F3N4O7
Additionnal Information
DDO-2728 is a selective pyrazolopyrimidine-based inhibitor of ALKBH5 with an IC50 of 2.97 μM. It increases the levels of N6-methyladenosine (m6A) modifications in acute myeloid leukemia (AML) cells and exhibits antiproliferative activity in these cells. It also demonstrates anti-tumor efficacy in the MV4−11 xenograft model.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
125568-APC 100 µL
CYP26B1 (Cytochrome P450 26B1, Retinoic Acid-metabolizing Cytochrome, Cytochrome P450 26A2, Cytochrome P450 Retinoic Acid-inactivating 2, Cytochrome P450RAI-2, CYP26A2, P450RAI2) (APC)
Sign In for Pricing
View Details 
GTR15324195 1 Vial
Lentiviral human KRTAP6-1 shRNA (UAS) - Lentiviral human KRTAP6-1 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 
MBS1129489-01 0.02 mg (E-Coli)
Recombinant Bordetella petrii 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details MBS1129489-02 0.1 mg (E-Coli)
Recombinant Bordetella petrii 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details